Skip to main content
SpringerLink
Log in
Book cover

PET/CT-Atlas pp 819–844Cite as

Onkologische Orthopädie

  • Chapter

  • 3152 Accesses

Zusammenfassung

Einleitung Die Knochenszintigraphie zählt seit über 40 Jahren zu den häufigsten Untersuchungen in der Nuklearmedizin, auch wenn zugestanden wird, dass CT und v. a. MRT zu einer Reduktion der Nachfrage beigetragen haben (s. Literatur auf DVD 12.1]). Durch die Entwicklung von SPECT gab es eine gewisse Gegenbewegung: Knochentumoren, Fieber unklarer Genese, infektiöse und inflammatorische Erkrankungen, deren Ursache anderweitig nicht abklärbar ist, sind Indikationsspektrum der Szintigraphie mit 99m Tc-markierten Antigranulozyten-Antikörpern (Immunszintigraphie) [12.2].

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adams S, Hör G (2004) Nuklearmedizinische Diagnostik von Knochenentzündungen. In: Schnettler R, Steinau HU (Hrsg) Septische Knochenchirurgie. Thieme, Stuttgart, S 57–74

    Google Scholar 

  2. Berger F, Lee YP, Loening AM et al. (2002) Whole body skeletal imaging in mice utilizing micro-PET: optimization of reproducibility and applications in animal models of bone disease. Eur J Nucl Med Mol Imaging 29: 1225–1236

    Article  PubMed  CAS  Google Scholar 

  3. Brenner W, Conrad EU, Eary JF (2004) FDG PET imaging for grading and prediction of outcome in chrondrosarcoma patients. Eur J Nucl Med Mol Imaging 31: 189–195

    Article  PubMed  Google Scholar 

  4. Brenner W, Vernon C, Muzi M et al. (2004) Comparison of different quantitative approaches to 18F-fluoride PET scans. J Nucl Med 45: 1493–1500

    PubMed  CAS  Google Scholar 

  5. Cremerius U, Mumme T, Reinartz P et al. (2003) Analyse des 18F-FDG Speichermusters in der PET zur Diagnostik von septischer und aseptischer Lockerung bei Totalendoprothesen des Hüftgelenks. Nuklearmedizin 42: 234–239

    PubMed  CAS  Google Scholar 

  6. Even-Sapir E (2005) Imaging of malignant bone involvement by morphological scintigraphic and hybrid modalities. J Nucl Med 46: 1356–1367

    PubMed  Google Scholar 

  7. Even-Sapir E, Metser U, Flusser G et al. (2004) Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. J Nucl Med 45: 272–278

    PubMed  Google Scholar 

  8. Folpe AL, Lyles RH, Sprouse JT et al. (2000) (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathological grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res 6: 12379–12387

    Google Scholar 

  9. Franzius C, Sciuk J (2000) Positronenemissionstomographie mit F-18-Fluor-Desoxyglukose (FDG-PET)im Kinder- und Jugendalter: Erfahrungen an über 500 pädiatrischen Patienten. Der Nuklearmediziner 23: 287–295

    Google Scholar 

  10. Franzius C, Sciuk J, Brinkschmidt C et al. (2000) Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clin Nucl Med 25: 874–881

    Article  PubMed  CAS  Google Scholar 

  11. Franzius C, Sciuk J, Daldrup-Link HE et al. (2000) FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med 27: 1305–1311

    Article  PubMed  CAS  Google Scholar 

  12. Franzius C, Daldrup-Link HE, Sciuk J et al. (2001) FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol 12: 479–486

    Article  PubMed  CAS  Google Scholar 

  13. Franzius C, Bielack S, Flege S et al. (2002) Prognostic significance of 18F-FDG and 99mTc-methylene diphosphonate uptake in primary osteosarcoma. J Nucl Med 43: 1012–1017

    PubMed  CAS  Google Scholar 

  14. Franzius C, Daldrup-Link HE, Wagner-Bohn A et al. (2002) FDGPET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. Ann Oncol 13: 157–160

    Article  PubMed  CAS  Google Scholar 

  15. Hartmann A, Eid K, Dora C et al. (2007) Diagnostic value of 18FFDG PET/CT in trauma patients with suspected chronic osteomyelitis. Eur J Nucl Med Mol Imaging 34: 704–714

    Article  PubMed  Google Scholar 

  16. Hoegerle S, Juengling F, Otte A et al. (1998) Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging? Radiology 209: 253–258

    PubMed  CAS  Google Scholar 

  17. Hör G, Frey KW, Keyl W, Hertel E (1969) Vergleich von Szintigraphie und Röntgendiagnostik bei Osteomyelitis. Fortschr Röntgenstr 110: 708–716

    Article  Google Scholar 

  18. Hör G, Keyl W, Langhammer H, Herzog M, Pabst HW (1975) Ergebnisvergleich der 99m-Tc-Polyphosphat-Kamera (Sequenz, Funktions)-Szintigraphie, der 85Sr-, 87m-Sr-Scannerszintigraphie und radiologischer Methoden in der Orthopädie. Nuklearmedizin 14: 37–45

    Google Scholar 

  19. Hsu WK, T B, Feely, Krenek L et al. (2007) The use of 18F-fluoride and 18F-FDG PET scans to assess fracture healing in a rat femur model. Eur J Nucl Med Mol Imaging 34: 1291–1301

    Article  PubMed  CAS  Google Scholar 

  20. Lodge MA, Lucas JD, Marsden PK et al. (1999) A PET study of 18FDG uptake in soft tissue masses. Eur J Nucl Med 26: 22–30

    Article  PubMed  CAS  Google Scholar 

  21. Mullerad M, Eisenberg DP, Akhurst TJ et al. (2006) Use of positron emission tomography to target prostate cancer gene therapy by oncolytic herpes simplex virus. Mol Imaging Biol 8: 30–35

    Article  PubMed  Google Scholar 

  22. Piert M, Winter E, Becker GA, Bilger K et al. (1999) Allogenic bone graft viability after hip revision arthroplasty assessed by dynamic [18F]fluoride ion positron emission tomography. Eur J Nucl Med 26: 615–624

    Article  PubMed  CAS  Google Scholar 

  23. Sasaki M, Ichiya Y, Kuwabara Y, Otsuka M, Fukumura T, Kawai Y, Koga H, Masuda K (1993) Fluorine-18-fluorodeoxyglucose positron emission tomography in technetium-99m-hydroxymethylenediphosphate negative bone tumors. J Nucl Med 34: 288–290

    PubMed  CAS  Google Scholar 

  24. Schirrmeister H, Glatting G, Hetzel J et al. (2001) Prospective evaluation of the clinical value of planar bone scans, SPECT, and 18F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med 42: 1800–1804

    PubMed  CAS  Google Scholar 

  25. Zhuang H, Duarte PS, Pourdehnad M et al. (2001) The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants. J Nucl Med 42: 44–48

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diagnostisch Therapeutisches Zentrum, Kadiner Straße 23, 10243, Berlin

    Prof. Dr. med. Wolfgang Mohnike

  2. Kuckucksweg 25, 61462, Königstein

    Prof. Dr. med. Gustav Hör

  3. UCLA Molecular & Medical Pharmacology, 956948, 90095-6948, B2-085J CHS, Los Angeles, USA

    Prof. Dr. med. Heinrich Schelbert

Authors
  1. Prof. Dr. med. Wolfgang Mohnike
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Gustav Hör
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prof. Dr. med. Heinrich Schelbert
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Mohnike, W., Hör, G., Schelbert, H. (2011). Onkologische Orthopädie. In: PET/CT-Atlas. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-17805-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-17805-4_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-17804-7

  • Online ISBN: 978-3-642-17805-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation